International survey finds geographic variation in the subtype frequencies in biopsied patients.
Except for gabapentin, evidence for 38 other treatments is weak and limited by small studies with a high risk of bias, new review finds.
Nearly 1 in 3 patients diagnosed with Gleason 3+4 favorable intermediate-risk prostate cancer had their disease upgraded or upstaged at radical prostatectomy.
The odds of starting hemodialysis with an arteriovenous fistula are 31% lower for women compared with men.
A new study found a 52% higher risk for the future development of Parkinson’s disease among men with erectile dysfunction.
Use of sevelamer was associated with a 14% decreased risk of death compared with non-use.